Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen-receptor Positive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02668666
What this trial is testing

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of BreastHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEstrogen Receptor Positive Breast Cancer+2 more
Oana Danciu, MD 49
Testing effectiveness (Phase 2)Study completedNCT00828854
What this trial is testing

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

Who this might be right for
ER+ Breast Cancer
Syndax Pharmaceuticals 27
Testing effectiveness (Phase 2)Looking for participantsNCT06028022
What this trial is testing

Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors

Who this might be right for
Estrogen Receptor-Positive Breast Carcinoma
Mayo Clinic 80
Large-scale testing (Phase 3)WithdrawnNCT00053339
What this trial is testing

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

Who this might be right for
Stage IV Breast CancerRecurrent Breast Cancer
Alliance for Clinical Trials in Oncology
Early research (Phase 1)Study completedNCT02599714
What this trial is testing

Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

Who this might be right for
Advanced and Metastatic Breast Cancer
AstraZeneca 54
Testing effectiveness (Phase 2)Looking for participantsNCT07287098
What this trial is testing

Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 600
Large-scale testing (Phase 3)Study completedNCT00949598
What this trial is testing

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 177
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105632
What this trial is testing

Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Who this might be right for
Advanced or Metastatic Breast Cancer
Pfizer 333
Large-scale testing (Phase 3)Looking for participantsNCT05512364
What this trial is testing

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)

Who this might be right for
ER-positive Breast CancerHER2-negative Breast CancerStage IIB Breast Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 220
Testing effectiveness (Phase 2)Study completedNCT00464516
What this trial is testing

Preoperative Estetrol in Breast Cancer

Who this might be right for
Breast Cancer
Pantarhei Bioscience 30
Large-scale testing (Phase 3)Ended earlyNCT01548534
What this trial is testing

A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor+1 more
University Hospital, Tours 65
Not applicableNot Yet RecruitingNCT06729099
What this trial is testing

Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients

Who this might be right for
Breast Cancer, Estrogen Receptor-Positive
Assiut University 128
Not applicableUnknownNCT05651087
What this trial is testing

Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient

Who this might be right for
Hormone Receptor-positive Breast Cancer
Gun Oh Chong 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844
What this trial is testing

Breast Cancer Study of Preoperative Pembrolizumab + Radiation

Who this might be right for
Breast Cancer
Stephen Shiao 66
Large-scale testing (Phase 3)Looking for participantsNCT04601116
What this trial is testing

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Who this might be right for
Breast Cancer FemaleEstrogen Receptor Positive Tumor
Aarhus University Hospital 3,360
Testing effectiveness (Phase 2)Active Not RecruitingNCT01992952
What this trial is testing

Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast Cancer
Velindre NHS Trust 149
Early research (Phase 1)Active Not RecruitingNCT06533059
What this trial is testing

Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

Who this might be right for
CancerBreast CancerEndometrial Cancer+2 more
Alterome Therapeutics, Inc. 110
Not applicableLooking for participantsNCT06127979
What this trial is testing

Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT06452394
What this trial is testing

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

Who this might be right for
Breast Cancer
Swiss Cancer Institute 50
Next Page